• Profile
Close

Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study

Journal of the American Academy of Dermatology Nov 05, 2017

Puig L, et al. - A comparative analysis was pursued of the effect of secukinumab and ustekinumab on complete relief from psoriasis-related symptoms, time to health-related quality of life (HRQOL) response, and cumulative benefit among patients with moderate-to-severe plaque psoriasis. In comparison with the ustekinumab treatment, therapy with secukinumab yielded greater and sustained benefits on the patients' lives.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay